HEADER MEMBRANE PROTEIN 22-JUN-23 8JTS TITLE HOCT1 IN COMPLEX WITH METFORMIN IN OUTWARD OPEN CONFORMATION COMPND MOL_ID: 1; COMPND 2 MOLECULE: SOLUTE CARRIER FAMILY 22 MEMBER 1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: ORGANIC CATION TRANSPORTER 1,HOCT1; COMPND 5 ENGINEERED: YES; COMPND 6 OTHER_DETAILS: METFORMIN SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: SLC22A1, OCT1; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS SLC, TRANSPORTER, MEMBRANE PROTEIN EXPDTA ELECTRON MICROSCOPY AUTHOR S.ZHANG,A.ZHU,F.KONG,J.CHEN,B.LAN,G.HE,K.GAO,L.CHENG,C.YAN,L.CHEN, AUTHOR 2 X.LIU REVDAT 1 27-MAR-24 8JTS 0 JRNL AUTH S.ZHANG,A.ZHU,F.KONG,J.CHEN,B.LAN,G.HE,K.GAO,L.CHENG,X.SUN, JRNL AUTH 2 C.YAN,L.CHEN,X.LIU JRNL TITL STRUCTURAL INSIGHTS INTO HUMAN ORGANIC CATION TRANSPORTER 1 JRNL TITL 2 TRANSPORT AND INHIBITION. JRNL REF CELL DISCOV V. 10 30 2024 JRNL REFN ESSN 2056-5968 JRNL PMID 38485705 JRNL DOI 10.1038/S41421-024-00664-1 REMARK 2 REMARK 2 RESOLUTION. 4.14 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : NULL REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 4.140 REMARK 3 NUMBER OF PARTICLES : 342359 REMARK 3 CTF CORRECTION METHOD : NONE REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 8JTS COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBC ON 29-JUN-23. REMARK 100 THE DEPOSITION ID IS D_1300038862. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : HUMAN ORGANIC CATION REMARK 245 TRANSPORTER IN COMPELX WTIH REMARK 245 METFORMIN IN OUTWARD OPEN REMARK 245 CONFORMATION REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : NULL REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 8.00 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN REMARK 245 DETECTOR TYPE : GATAN K3 (6K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 1100.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 1500.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 5000.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 GLN A 51 REMARK 465 SER A 52 REMARK 465 PRO A 53 REMARK 465 GLY A 54 REMARK 465 VAL A 55 REMARK 465 ALA A 56 REMARK 465 GLU A 57 REMARK 465 LEU A 58 REMARK 465 SER A 59 REMARK 465 GLN A 60 REMARK 465 ARG A 61 REMARK 465 CYS A 62 REMARK 465 GLY A 63 REMARK 465 TRP A 64 REMARK 465 SER A 65 REMARK 465 PRO A 66 REMARK 465 ALA A 67 REMARK 465 GLU A 68 REMARK 465 GLU A 69 REMARK 465 LEU A 70 REMARK 465 ASN A 71 REMARK 465 TYR A 72 REMARK 465 THR A 73 REMARK 465 VAL A 74 REMARK 465 PRO A 75 REMARK 465 GLY A 76 REMARK 465 LEU A 77 REMARK 465 GLY A 78 REMARK 465 PRO A 79 REMARK 465 ALA A 80 REMARK 465 GLY A 81 REMARK 465 GLU A 82 REMARK 465 ALA A 83 REMARK 465 PHE A 84 REMARK 465 LEU A 85 REMARK 465 GLY A 86 REMARK 465 GLN A 87 REMARK 465 CYS A 88 REMARK 465 ARG A 89 REMARK 465 ARG A 90 REMARK 465 TYR A 91 REMARK 465 GLU A 92 REMARK 465 VAL A 93 REMARK 465 ASP A 94 REMARK 465 TRP A 95 REMARK 465 ASN A 96 REMARK 465 GLN A 97 REMARK 465 SER A 98 REMARK 465 ALA A 99 REMARK 465 LEU A 100 REMARK 465 SER A 101 REMARK 465 CYS A 102 REMARK 465 VAL A 103 REMARK 465 ASP A 104 REMARK 465 PRO A 105 REMARK 465 LEU A 106 REMARK 465 ALA A 107 REMARK 465 SER A 108 REMARK 465 LEU A 109 REMARK 465 ALA A 110 REMARK 465 THR A 111 REMARK 465 ASN A 112 REMARK 465 ARG A 113 REMARK 465 SER A 114 REMARK 465 HIS A 115 REMARK 465 LEU A 116 REMARK 465 PRO A 117 REMARK 465 LEU A 118 REMARK 465 GLY A 119 REMARK 465 PRO A 120 REMARK 465 ARG A 533 REMARK 465 LYS A 534 REMARK 465 ALA A 535 REMARK 465 LYS A 536 REMARK 465 PRO A 537 REMARK 465 LYS A 538 REMARK 465 GLU A 539 REMARK 465 ASN A 540 REMARK 465 THR A 541 REMARK 465 ILE A 542 REMARK 465 TYR A 543 REMARK 465 LEU A 544 REMARK 465 LYS A 545 REMARK 465 VAL A 546 REMARK 465 GLN A 547 REMARK 465 THR A 548 REMARK 465 SER A 549 REMARK 465 GLU A 550 REMARK 465 PRO A 551 REMARK 465 SER A 552 REMARK 465 GLY A 553 REMARK 465 THR A 554 REMARK 465 GLU A 555 REMARK 465 ASP A 556 REMARK 465 GLN A 557 REMARK 465 VAL A 558 REMARK 465 ASP A 559 REMARK 465 PRO A 560 REMARK 465 ARG A 561 REMARK 465 LEU A 562 REMARK 465 ILE A 563 REMARK 465 ASP A 564 REMARK 465 GLY A 565 REMARK 465 LYS A 566 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 9 CG CD OE1 OE2 REMARK 470 VAL A 11 CG1 CG2 REMARK 470 LYS A 19 CG CD CE NZ REMARK 470 PHE A 44 CG CD1 CD2 CE1 CE2 CZ REMARK 470 HIS A 48 CG ND1 CD2 CE1 NE2 REMARK 470 HIS A 49 CG ND1 CD2 CE1 NE2 REMARK 470 CYS A 50 SG REMARK 470 CYS A 121 SG REMARK 470 GLN A 122 CG CD OE1 NE2 REMARK 470 ASP A 123 CG OD1 OD2 REMARK 470 TYR A 127 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ASP A 128 CG OD1 OD2 REMARK 470 ASP A 144 CG OD1 OD2 REMARK 470 LYS A 147 CG CD CE NZ REMARK 470 SER A 153 OG REMARK 470 ARG A 172 CG CD NE CZ NH1 NH2 REMARK 470 MET A 200 CG SD CE REMARK 470 ARG A 233 CG CD NE CZ NH1 NH2 REMARK 470 TYR A 279 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 GLN A 292 CG CD OE1 NE2 REMARK 470 ARG A 294 CG CD NE CZ NH1 NH2 REMARK 470 ASN A 295 CG OD1 ND2 REMARK 470 THR A 296 OG1 CG2 REMARK 470 LYS A 300 CG CD CE NZ REMARK 470 GLN A 307 CG CD OE1 NE2 REMARK 470 LYS A 308 CG CD CE NZ REMARK 470 ASN A 309 CG OD1 ND2 REMARK 470 LYS A 311 CG CD CE NZ REMARK 470 LEU A 312 CG CD1 CD2 REMARK 470 ASP A 316 CG OD1 OD2 REMARK 470 LEU A 317 CG CD1 CD2 REMARK 470 LYS A 318 CG CD CE NZ REMARK 470 MET A 319 CG SD CE REMARK 470 LEU A 322 CG CD1 CD2 REMARK 470 GLU A 323 CG CD OE1 OE2 REMARK 470 GLU A 324 CG CD OE1 OE2 REMARK 470 GLU A 328 CG CD OE1 OE2 REMARK 470 LYS A 329 CG CD CE NZ REMARK 470 PHE A 338 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ARG A 339 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 342 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 344 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 345 CG CD CE NZ REMARK 470 ARG A 346 CG CD NE CZ NH1 NH2 REMARK 470 MET A 368 CG SD CE REMARK 470 GLU A 386 CG CD OE1 OE2 REMARK 470 MET A 406 CG SD CE REMARK 470 MET A 408 CG SD CE REMARK 470 MET A 420 CG SD CE REMARK 470 LEU A 427 CG CD1 CD2 REMARK 470 HIS A 428 CG ND1 CD2 CE1 NE2 REMARK 470 LEU A 430 CG CD1 CD2 REMARK 470 ILE A 433 CG1 CG2 CD1 REMARK 470 TYR A 457 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ARG A 462 CG CD NE CZ NH1 NH2 REMARK 470 PHE A 485 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LEU A 487 CG CD1 CD2 REMARK 470 ARG A 488 CG CD NE CZ NH1 NH2 REMARK 470 LEU A 494 CG CD1 CD2 REMARK 470 LEU A 498 CG CD1 CD2 REMARK 470 LEU A 505 CG CD1 CD2 REMARK 470 THR A 510 OG1 CG2 REMARK 470 LEU A 511 CG CD1 CD2 REMARK 470 LEU A 512 CG CD1 CD2 REMARK 470 GLU A 515 CG CD OE1 OE2 REMARK 470 THR A 516 OG1 CG2 REMARK 470 LYS A 517 CG CD CE NZ REMARK 470 GLU A 523 CG CD OE1 OE2 REMARK 470 LYS A 526 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 197 49.18 -89.90 REMARK 500 ASN A 309 48.66 -94.86 REMARK 500 ASN A 374 -0.53 66.77 REMARK 500 ILE A 403 -56.10 -125.19 REMARK 500 LEU A 456 50.15 -91.38 REMARK 500 GLU A 515 -128.90 58.80 REMARK 500 MET A 525 -7.45 68.71 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-36651 RELATED DB: EMDB REMARK 900 HOCT1 IN COMPLEX WITH METFORMIN IN OUTWARD OPEN CONFORMATION DBREF 8JTS A 1 554 UNP O15245 S22A1_HUMAN 1 554 SEQADV 8JTS GLU A 555 UNP O15245 EXPRESSION TAG SEQADV 8JTS ASP A 556 UNP O15245 EXPRESSION TAG SEQADV 8JTS GLN A 557 UNP O15245 EXPRESSION TAG SEQADV 8JTS VAL A 558 UNP O15245 EXPRESSION TAG SEQADV 8JTS ASP A 559 UNP O15245 EXPRESSION TAG SEQADV 8JTS PRO A 560 UNP O15245 EXPRESSION TAG SEQADV 8JTS ARG A 561 UNP O15245 EXPRESSION TAG SEQADV 8JTS LEU A 562 UNP O15245 EXPRESSION TAG SEQADV 8JTS ILE A 563 UNP O15245 EXPRESSION TAG SEQADV 8JTS ASP A 564 UNP O15245 EXPRESSION TAG SEQADV 8JTS GLY A 565 UNP O15245 EXPRESSION TAG SEQADV 8JTS LYS A 566 UNP O15245 EXPRESSION TAG SEQRES 1 A 566 MET PRO THR VAL ASP ASP ILE LEU GLU GLN VAL GLY GLU SEQRES 2 A 566 SER GLY TRP PHE GLN LYS GLN ALA PHE LEU ILE LEU CYS SEQRES 3 A 566 LEU LEU SER ALA ALA PHE ALA PRO ILE CYS VAL GLY ILE SEQRES 4 A 566 VAL PHE LEU GLY PHE THR PRO ASP HIS HIS CYS GLN SER SEQRES 5 A 566 PRO GLY VAL ALA GLU LEU SER GLN ARG CYS GLY TRP SER SEQRES 6 A 566 PRO ALA GLU GLU LEU ASN TYR THR VAL PRO GLY LEU GLY SEQRES 7 A 566 PRO ALA GLY GLU ALA PHE LEU GLY GLN CYS ARG ARG TYR SEQRES 8 A 566 GLU VAL ASP TRP ASN GLN SER ALA LEU SER CYS VAL ASP SEQRES 9 A 566 PRO LEU ALA SER LEU ALA THR ASN ARG SER HIS LEU PRO SEQRES 10 A 566 LEU GLY PRO CYS GLN ASP GLY TRP VAL TYR ASP THR PRO SEQRES 11 A 566 GLY SER SER ILE VAL THR GLU PHE ASN LEU VAL CYS ALA SEQRES 12 A 566 ASP SER TRP LYS LEU ASP LEU PHE GLN SER CYS LEU ASN SEQRES 13 A 566 ALA GLY PHE LEU PHE GLY SER LEU GLY VAL GLY TYR PHE SEQRES 14 A 566 ALA ASP ARG PHE GLY ARG LYS LEU CYS LEU LEU GLY THR SEQRES 15 A 566 VAL LEU VAL ASN ALA VAL SER GLY VAL LEU MET ALA PHE SEQRES 16 A 566 SER PRO ASN TYR MET SER MET LEU LEU PHE ARG LEU LEU SEQRES 17 A 566 GLN GLY LEU VAL SER LYS GLY ASN TRP MET ALA GLY TYR SEQRES 18 A 566 THR LEU ILE THR GLU PHE VAL GLY SER GLY SER ARG ARG SEQRES 19 A 566 THR VAL ALA ILE MET TYR GLN MET ALA PHE THR VAL GLY SEQRES 20 A 566 LEU VAL ALA LEU THR GLY LEU ALA TYR ALA LEU PRO HIS SEQRES 21 A 566 TRP ARG TRP LEU GLN LEU ALA VAL SER LEU PRO THR PHE SEQRES 22 A 566 LEU PHE LEU LEU TYR TYR TRP CYS VAL PRO GLU SER PRO SEQRES 23 A 566 ARG TRP LEU LEU SER GLN LYS ARG ASN THR GLU ALA ILE SEQRES 24 A 566 LYS ILE MET ASP HIS ILE ALA GLN LYS ASN GLY LYS LEU SEQRES 25 A 566 PRO PRO ALA ASP LEU LYS MET LEU SER LEU GLU GLU ASP SEQRES 26 A 566 VAL THR GLU LYS LEU SER PRO SER PHE ALA ASP LEU PHE SEQRES 27 A 566 ARG THR PRO ARG LEU ARG LYS ARG THR PHE ILE LEU MET SEQRES 28 A 566 TYR LEU TRP PHE THR ASP SER VAL LEU TYR GLN GLY LEU SEQRES 29 A 566 ILE LEU HIS MET GLY ALA THR SER GLY ASN LEU TYR LEU SEQRES 30 A 566 ASP PHE LEU TYR SER ALA LEU VAL GLU ILE PRO GLY ALA SEQRES 31 A 566 PHE ILE ALA LEU ILE THR ILE ASP ARG VAL GLY ARG ILE SEQRES 32 A 566 TYR PRO MET ALA MET SER ASN LEU LEU ALA GLY ALA ALA SEQRES 33 A 566 CYS LEU VAL MET ILE PHE ILE SER PRO ASP LEU HIS TRP SEQRES 34 A 566 LEU ASN ILE ILE ILE MET CYS VAL GLY ARG MET GLY ILE SEQRES 35 A 566 THR ILE ALA ILE GLN MET ILE CYS LEU VAL ASN ALA GLU SEQRES 36 A 566 LEU TYR PRO THR PHE VAL ARG ASN LEU GLY VAL MET VAL SEQRES 37 A 566 CYS SER SER LEU CYS ASP ILE GLY GLY ILE ILE THR PRO SEQRES 38 A 566 PHE ILE VAL PHE ARG LEU ARG GLU VAL TRP GLN ALA LEU SEQRES 39 A 566 PRO LEU ILE LEU PHE ALA VAL LEU GLY LEU LEU ALA ALA SEQRES 40 A 566 GLY VAL THR LEU LEU LEU PRO GLU THR LYS GLY VAL ALA SEQRES 41 A 566 LEU PRO GLU THR MET LYS ASP ALA GLU ASN LEU GLY ARG SEQRES 42 A 566 LYS ALA LYS PRO LYS GLU ASN THR ILE TYR LEU LYS VAL SEQRES 43 A 566 GLN THR SER GLU PRO SER GLY THR GLU ASP GLN VAL ASP SEQRES 44 A 566 PRO ARG LEU ILE ASP GLY LYS HET MF8 A 601 9 HETNAM MF8 METFORMIN HETSYN MF8 N,N-DIMETHYLIMIDODICARBONIMIDIC DIAMIDE FORMUL 2 MF8 C4 H11 N5 HELIX 1 AA1 THR A 3 GLY A 12 1 10 HELIX 2 AA2 GLY A 15 ALA A 30 1 16 HELIX 3 AA3 PHE A 32 VAL A 37 1 6 HELIX 4 AA4 GLY A 38 GLY A 43 1 6 HELIX 5 AA5 SER A 133 ASN A 139 1 7 HELIX 6 AA6 TRP A 146 VAL A 166 1 21 HELIX 7 AA7 GLY A 167 ARG A 172 1 6 HELIX 8 AA8 GLY A 174 PHE A 195 1 22 HELIX 9 AA9 TYR A 199 VAL A 228 1 30 HELIX 10 AB1 SER A 232 LEU A 258 1 27 HELIX 11 AB2 HIS A 260 TYR A 279 1 20 HELIX 12 AB3 SER A 285 SER A 291 1 7 HELIX 13 AB4 ASN A 295 ASN A 309 1 15 HELIX 14 AB5 ALA A 315 LEU A 320 1 6 HELIX 15 AB6 THR A 340 MET A 368 1 29 HELIX 16 AB7 TYR A 376 ILE A 397 1 22 HELIX 17 AB8 ILE A 403 ILE A 423 1 21 HELIX 18 AB9 TRP A 429 LEU A 456 1 28 HELIX 19 AC1 PRO A 458 ASN A 463 1 6 HELIX 20 AC2 GLY A 465 SER A 471 1 7 HELIX 21 AC3 CYS A 473 TRP A 491 1 19 HELIX 22 AC4 ALA A 493 THR A 510 1 18 HELIX 23 AC5 LYS A 526 LEU A 531 1 6 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000